Also known as the ‘pro hormone’, androstenedione or products in the global androstenedione market are used primarily to boost the hormones estrogen and testosterone in human bodies. Products in the global androstenedione market are administered orally to boost the levels of these hormones. They are linked with ability to strengthen physical abilities, increase stamina, increase sexual appetite, promote enhanced regeneration during exercise and other physically strenuous activities, and keeping the red blood cells intact. These qualities are fostering the development of the global androstenedione market. However, products in the global androstenedione market display certain side effects, especially in men. These include low production of sperm, risk of heart diseases, sustained painful erections, and behavioral changes, among others. This can restrict the growth of the global androstenedione market in coming years.
Products in the global androstenedione market are also used in the production of birth control or contraceptive pills for women. Side effects of the products in global androstenedione market for women can include depression and irregular menstrual cycles. Furthermore, androstenedione is considered to be toxic for the liver and can increase the risk of pancreatic, lung, or breast cancer after prolonged usage. This also serves as a demotivating factor for the uptake of products in the global androstenedione market. However, rising prevalence of sclerosis and multiple infectious inflammation disorders can stimulate high growth in the global androstenedione market in coming years.
Androstenedione Market Introduction
Androstenedione is a 19-carbon steroid hormone produced in the adrenal glands. It is known to stimulate the development of sex organs, sexual characters, and favor the development of masculine characteristics. It also shows significant effects on scalp and body hair in humans. It is considered to be a male sex hormone; however, it is present in the blood of both men and women and is a precursor that can be converted by the body into more potent androgens, such as testosterone, or converted into the female hormone estrogen.
Androstenedione hormone secretion is controlled by two key parts of the brain (the hypothalamus and pituitary gland) which are known to control androstenedione secretion from the testes, ovaries, and adrenal cortex. Overproduction of androstenedione could lead to an imbalance in estrogen and testosterone production, leading to changes such as breast development in men and hirsutism, amenorrhoea, worsening acne, and changes to the genitalia in women.
Androstenedione Market- Competitive Landscape
Leading market players are focusing on further innovative developments of androstenedione new formulation to overcome existing limits and enhance the efficiency such as Mattern is developing MetP’s Androstenedione Nasal Gel that is fast absorbed without first-pass hepatic and intestinal metabolism and therefore can be applied in much lower and safer doses.
Identify the Key Factors that will drive your Company’s Growth. Request a Brochure of this Report here
Founded in 1849, Mylan N.V. is headquartered in New York, U.S. The company is a pharmaceutical company offering generic and branded medications. It is a leader in the U.S. generics industry. Approximately one in every 14 prescriptions dispensed in the U.S. is a Mylan product. Mylan N.V. offers more than 7,500 marketed generic and branded generic products as well as OTC products. The company operates 12 injectables facilities, eight of which are based in India. Mylan N.V. operates in more than 165 countries. North America contributes significantly to the company’s revenue. The company enjoys significant presence in the U.S., Australia, and France.
Founded in 1849, Pfizer, Inc. is headquartered in New York, U.S. The is a global pharmaceutical company that develops, manufactures, and markets prescription medicines in 11 therapeutic segments including cardiovascular, oncology, neuroscience, pain, and infectious diseases. The company offers a range of medicines and vaccines as well as consumer health care products for the prevention and treatment of infectious and chronic diseases for all age groups. It operates through two business units: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The company has more than 95 products in different stages of pipeline studies for disease indications, such as metabolic risks and cardiovascular risks, oncology, inflammation and immunology, neuroscience, and rare diseases.
Founded in 2013, AbbVie, Inc. is headquartered in Illinois, the U.S. The company is a research-oriented, global biopharmaceutical company that engages in the development and marketing of advanced therapies for highly complex and serious diseases. The company is having promising pipeline of new medicines, in the clinical development stage across fields, such as, virology/liver diseases (including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), immunology, oncology, neurological diseases, dermatology, and women's health
Teva Pharmaceutical Industries Ltd.
Founded in 1944, Teva Pharmaceutical Industries Ltd. is headquartered in Petah Tikva, Israel. The company is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals worldwide. It is a leading generic drug company in the U.S. and Europe. The company delivers high-quality and patient-centric health care solutions across the globe. It has a wide portfolio of generic drugs with more than 1,000 molecules in almost every therapeutic area. The company primarily operates through two business segments: generic medicines and specialty medicines.
Expanding Operations in Future? To get the perfect launch ask for a Custom Report here
Androstenedione Market – Dynamics
Consumer Preference Increasing for Androstenedione Product
Consumer preference for androstenedione based products is expected to significantly increase over the forecast period. Manufacturers of androstenedione products are focusing on product development and optimization of products according to consumer demand. Growth in the market is increasing by factor such as increase testosterone levels, Heighten sexual arousal and function, enhance recovery and growth from exercise. Growing fitness interest among young people is paving way for androstenedione products. To achieve stringent fitness targets, sports persons and fitness enthusiasts consume androstenedione products.
In 2017, In the U.S., fertility control rate decreased by 16%, thereby augmenting the growth of androstenedione market.
Development of new formulations to offer new market leads
Localized drug delivery techniques for treatment such as the usage of creams that show better efficacy and performance are likely to be frequently sought after by medical professionals and facilities who have been dogged by severe shortcomings of current drugs. Successful observations of combination therapy have been encouraging and market leaders need to focus on combination molecules in order to gain a significant advantage due to several benefits such as lower drug doses and reduced incidence of adverse effects.
Androstenedione Market– Segmentation
Based on the application, the Androstenedione market is segmented into
- Delayed Puberty
Based on the product type, the Androstenedione market is segmented into
Based on the distribution channel, the Androstenedione market is segmented into
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.